COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,220 Articles (22,733 medRxiv, 8,487 bioRxiv)

Most recent first Previous |  Page 485: Articles 4841-4850  | Next

Transcription regulation of SARS-CoV-2 receptor ACE2 by Sp1: a potential therapeutic target
Han, H., Luo, R.-H., Long, X.-Y., Wang, L.-Q., Zhu, Q., Tang, X.-Y., Zhu, R., Ma, Y.-C., Zheng, Y.-T., Zou, C.-g.
10.1101/2023.02.14.528496 — Posted: 2023-02-14
P-Selectin promotes SARS-CoV-2 interactions with platelets and the endothelium
Moreno, C. L., Castanheira, F. V. S., Stella, A. O., Chung, F., Aggarwal, A., Cole, A. J., Loo, L., Dupuy, A., Kong, Y., Hagimola, L., Fenwick, J., Coleman, P., Wilson, M., Bui-Marinos, M., Hesselson, D., Gamble, J., Passam, F., Turville, S., Kubes, P., Neely, G. G.
10.1101/2023.02.13.528235 — Posted: 2023-02-14
Propylene glycol inactivates respiratory viruses and prevents airborne transmission
Styles, C. T., Zhou, J., Flight, K. E., Brown, J. C., Vanden Oever, M., Peacock, T. P., Wang, Z., Millns, R., O'Neill, J. S., Barclay, W. S., Tregoning, J. S., Edgar, R. S.
10.1101/2023.02.13.528349 — Posted: 2023-02-14
SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent Booster
Wang, Q., Bowen, A. D., Tam, A. R., Valdez, R., Stoneman, E., Mellis, I. A., Gordon, A., Liu, L., Ho, D. D.
10.1101/2023.02.13.528341 — Posted: 2023-02-14
Two dimensions of chemical variation of the human microbiome across body sites and in COVID-19 patients
Dick, J. M.
10.1101/2023.02.12.528246 — Posted: 2023-02-13
Olivar: fully automated and variant aware primer design for multiplex tiled amplicon sequencing of pathogen genomes
Wang, M. X., Lou, E. G., Sapoval, N., Kim, E., Kalvapalle, P., Kille, B., Elworth, R. A. L., Liu, Y., Fu, Y., Stadler, L. B., Treangen, T. J.
10.1101/2023.02.11.528155 — Posted: 2023-02-13
Positing changes in neutralizing antibody activity for SARS-CoV-2 XBB.1.5 using in silico protein modeling
Ford, C. T., Yasa, S., Jacob Machado, D. T., White, R. A., Janies, D. A.
10.1101/2023.02.10.528025 — Posted: 2023-02-13
LINE1-mediated reverse transcription and genomic integration of SARS-CoV-2 mRNA detected in virus-infected but not in viral mRNA-transfected cells
Zhang, L., Bisht, P., Flamier, A., Barrasa, M. I., Richards, A., Hughes, S. H., Jaenisch, R.
10.1101/2023.02.10.527906 — Posted: 2023-02-13
Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease
Zhang, K., Ciesla, J. H., Eldin, P., Briant, L., Lentini, J. M., Ramos, J., Munger, J., Fu, D.
10.1101/2023.02.10.527147 — Posted: 2023-02-13
Nuclear export inhibitor Selinexor targeting XPO1 enhances coronavirus replication.
Rahman, M. M., Estifanos, B., Glenn, H. L., Kibler, K. V., Li, Y., Jacobs, B. L., McFadden, G., Hogue, B. G.
10.1101/2023.02.09.527884 — Posted: 2023-02-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).